Mansoor Raza Mirza
Net Worth

Last updated:

What is Mansoor Raza Mirza net worth?

The estimated net worth of Dr. Mansoor Raza Mirza is at least $3,679,905 as of 18 Dec 2020. He owns shares worth $62,000 as insider, has earned $2,071,305 from insider trading and has received compensation worth at least $1,546,600 in Karyopharm Therapeutics Inc..

What is the salary of Mansoor Raza Mirza?

Dr. Mansoor Raza Mirza salary is $140,600 per year as Clinical Consultant, Member of Scientific Advisory Board & Director in Karyopharm Therapeutics Inc..

How old is Mansoor Raza Mirza?

Dr. Mansoor Raza Mirza is 64 years old, born in 1961.

What stocks does Mansoor Raza Mirza currently own?

As insider, Dr. Mansoor Raza Mirza owns shares in one company:

Company Title Shares Price per share Total value
Karyopharm Therapeutics Inc. (KPTI) Clinical Consultant, Member of Scientific Advisory Board & Director 10,000 $6.2 $62,000

What does Karyopharm Therapeutics Inc. do?

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma, and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company has license agreement with Menarini Group to develop and commercialize NEXPOVIO for human oncology indications in Europe, including the United Kingdom; Latin America; and other countries. Its oral SINE compounds also designed to force nuclear accumulation in the levels of multiple tumor suppressor and growth regulatory proteins. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.

KPTI logo
KPTI
Karyopharm Therapeutics Inc.
$6.2

Mansoor Raza Mirza insider trading

Karyopharm Therapeutics Inc.

Dr. Mansoor Raza Mirza has made 24 insider trades between 2014-2020, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of KPTI stock worth $27,150 on 18 Dec 2020.

The largest trade he's ever made was exercising 20,000 units of KPTI stock on 7 Dec 2020. As of 18 Dec 2020 he still owns at least 10,000 units of KPTI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 5,000 $5.43 $27,150
Option
Common Stock 5,000 $5.43 $27,150
Option
Stock Option (right to buy) 5,000 $5.43 $27,150
Option
Common Stock 20,000 $5.43 $108,600
Option
Stock Option (right to buy) 20,000 $5.43 $108,600
Sale
Common Stock 20,000 $16.14 $322,820
Sale
Common Stock 5,000 $8.06 $40,300
Option
Stock Option (right to buy) 5,000 $8.06 $40,300
Option
Common Stock 5,000 $8.06 $40,300
Option
Stock Option (right to buy) 2,056 $8.06 $16,571
Option
Common Stock 2,056 $8.06 $16,571
Sale
Common Stock 2,056 $8.06 $16,571
Option
Common Stock 2,944 $8.06 $23,729
Option
Stock Option (right to buy) 2,944 $8.06 $23,729
Sale
Common Stock 2,944 $8.06 $23,729
Sale
Common Stock 12,121 $17.18 $208,239
Option
Common Stock 12,121 $1.49 $18,000
Option
Stock Option (right to buy) 12,121 $1.49 $18,000
Option
Stock Option (right to buy) 10,342 $5.64 $58,360
Option
Common Stock 10,342 $5.64 $58,360
Sale
Common Stock 10,342 $17.02 $176,031
Option
Common Stock 2,500 $3.56 $8,910
Option
Stock Option (right to buy) 2,500 $3.56 $8,910
Sale
Common Stock 2,500 $21 $52,500
Option
Stock Option (right to buy) 2,500 $1.49 $3,713
Sale
Common Stock 2,500 $1.49 $3,713
Option
Common Stock 2,500 $1.49 $3,713
Option
Common Stock 2,000 $0.88 $1,750
Option
Stock Option (right to buy) 2,000 $0.88 $1,750
Sale
Common Stock 2,000 $18 $36,000
Option
Common Stock 2,500 $0.26 $660
Option
Stock Option (right to buy) 2,500 $0.26 $660
Sale
Common Stock 2,500 $0.26 $660
Sale
Common Stock 2,500 $0.26 $660
Option
Stock Option (right to buy) 2,500 $0.26 $660
Option
Common Stock 2,500 $0.26 $660
Option
Common Stock 1,500 $0.26 $396
Sale
Common Stock 1,500 $0.26 $396
Option
Stock Option (right to buy) 1,500 $0.26 $396
Option
Stock Option (right to buy) 1,500 $0.26 $396
Option
Common Stock 1,500 $0.26 $396
Sale
Common Stock 1,500 $13 $19,500
Option
Common Stock 2,000 $0.26 $528
Sale
Common Stock 2,000 $0.26 $528
Option
Stock Option (right to buy) 2,000 $0.26 $528
Sale
Common Stock 2,882 $0.26 $761
Option
Stock Option (right to buy) 2,882 $0.26 $761
Option
Common Stock 2,882 $0.26 $761
Option
Stock Option (right to buy) 118 $0.26 $31
Option
Common Stock 118 $0.26 $31
Sale
Common Stock 118 $0.26 $31
Option
Common Stock 10,738 $5.1 $54,785
Sale
Common Stock 8,939 $7.52 $67,230
Option
Stock Option (Right to Buy) 4,677 $0.15 $697
Option
Common Stock 5,000 $45.18 $225,880
Option
Stock Option (Right to buy) 5,000 $45.18 $225,880
Sale
Common Stock 5,000 $45.18 $225,880
Option
Stock Option (Right to buy) 1,535 $0.03 $51
Option
Common Stock 1,535 $0.03 $51
Sale
Common Stock 5,000 $45.18 $225,880
Sale
Common Stock 5,000 $45.05 $225,255
Sale
Common Stock 5,000 $40.95 $204,750
Sale
Common Stock 3,500 $40.05 $140,161
Sale
Common Stock 1,500 $35.04 $52,560

Karyopharm Therapeutics key executives

Karyopharm Therapeutics Inc. executives and other stock owners filed with the SEC:

  • Dr. Mansoor Raza Mirza (64) Clinical Consultant, Member of Scientific Advisory Board & Director
  • Dr. Michael G. Kauffman M.D., Ph.D. (62) Co-Founder, Senior Clinical Advisor & Director
  • Dr. Sharon Shacham (55) Co-Founder, Chief Scientific Officer & Chairman of Scientific Advisory Board
  • Mr. Michael P. Mason CPA, M.B.A. (50) Senior Vice President, Chief Financial Officer & Treasurer
  • Mr. Richard A. Paulson M.B.A. (58) Pres, Chief Executive Officer & Director